Patrick G Lepore - Net Worth and Insider Trading
Patrick G Lepore Net Worth
The estimated net worth of Patrick G Lepore is at least $116,974 dollars as of 2024-11-29. Patrick G Lepore is the Director of VYNE Therapeutics Inc and owns about 36,472 shares of VYNE Therapeutics Inc (VYNE) stock worth over $107,592. Patrick G Lepore is the Director of Matinas BioPharma Holdings Inc and owns about 8,000 shares of Matinas BioPharma Holdings Inc (MTNB) stock worth over $5,030. Patrick G Lepore is also the Director of Lannett Co Inc and owns about 146,786 shares of Lannett Co Inc (LCINQ) stock worth over $4,352. Details can be seen in Patrick G Lepore's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Patrick G Lepore has not made any transactions after 2023-11-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Patrick G Lepore
Patrick G Lepore Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Patrick G Lepore owns 5 companies in total, including VYNE Therapeutics Inc (VYNE) , Lannett Co Inc (LCINQ) , and Matinas BioPharma Holdings Inc (MTNB) among others .
Click here to see the complete history of Patrick G Lepore’s form 4 insider trades.
Insider Ownership Summary of Patrick G Lepore
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VYNE | VYNE Therapeutics Inc | 2023-11-15 | director |
| LCINQ | Lannett Co Inc | 2022-11-10 | director |
| MTNB | Matinas BioPharma Holdings Inc | 2020-05-14 | director |
 | | 2017-12-07 | director |
| | 2016-10-26 | director |
Patrick G Lepore Latest Holdings Summary
Patrick G Lepore currently owns a total of 3 stocks. Among these stocks, Patrick G Lepore owns 36,472 shares of VYNE Therapeutics Inc (VYNE) as of November 15, 2023, with a value of $107,592 and a weighting of 91.98%. Patrick G Lepore owns 8,000 shares of Matinas BioPharma Holdings Inc (MTNB) as of May 14, 2020, with a value of $5,030 and a weighting of 4.3%. Patrick G Lepore also owns 146,786 shares of Lannett Co Inc (LCINQ) as of November 10, 2022, with a value of $4,352 and a weighting of 3.72%.
Latest Holdings of Patrick G Lepore
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VYNE | VYNE Therapeutics Inc | 2023-11-15 | 36,472 | 2.95 | 107,592 |
| MTNB | Matinas BioPharma Holdings Inc | 2020-05-14 | 8,000 | 0.63 | 5,030 |
| LCINQ | Lannett Co Inc | 2022-11-10 | 146,786 | 0.03 | 4,352 |
Holding Weightings of Patrick G Lepore
Patrick G Lepore Form 4 Trading Tracker
According to the SEC Form 4 filings, Patrick G Lepore has made a total of 7 transactions in VYNE Therapeutics Inc (VYNE) over the past 5 years, including 7 buys and 0 sells. The most-recent trade in VYNE Therapeutics Inc is the acquisition of 13,000 shares on November 15, 2023, which cost Patrick G Lepore around $50,830.
According to the SEC Form 4 filings, Patrick G Lepore has made a total of 1 transactions in Matinas BioPharma Holdings Inc (MTNB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Matinas BioPharma Holdings Inc is the acquisition of 2,000 shares on May 14, 2020, which cost Patrick G Lepore around $73,000.
According to the SEC Form 4 filings, Patrick G Lepore has made a total of 6 transactions in Lannett Co Inc (LCINQ) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Lannett Co Inc is the acquisition of 25,000 shares on November 10, 2022, which cost Patrick G Lepore around $49,000.
Insider Trading History of Patrick G Lepore
- 1
Patrick G Lepore Trading Performance
GuruFocus tracks the stock performance after each of Patrick G Lepore's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Patrick G Lepore is -5.3%. GuruFocus also compares Patrick G Lepore's trading performance to market benchmark return within the same time period. The performance of stocks bought by Patrick G Lepore within 3 months outperforms 9 times out of 23 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Patrick G Lepore's insider trading performs compared to the benchmark.
Performance of Patrick G Lepore
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.13 | | | | | |
| Relative Return to S&P 500(%) | 5.13 | | | | | |
Patrick G Lepore Ownership Network
Patrick G Lepore Owned Company Details
What does VYNE Therapeutics Inc do?
Who are the key executives at VYNE Therapeutics Inc?
Patrick G Lepore is the director of VYNE Therapeutics Inc. Other key executives at VYNE Therapeutics Inc include Chief Legal Officer and GC Mutya Harsch , 10 percent owner Perceptive Life Sciences Master Fund Ltd , and Interim CFO Tyler Zeronda .
VYNE Therapeutics Inc (VYNE) Insider Trades Summary
Over the past 18 months, Patrick G Lepore made 1 insider transaction in VYNE Therapeutics Inc (VYNE) with a net purchase of 13,000.
In summary, during the past 3 months, insiders sold 0 shares of VYNE Therapeutics Inc (VYNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of VYNE Therapeutics Inc (VYNE) were sold and 13,000 shares were bought by its insiders, resulting in a net purchase of 13,000 shares.
VYNE Therapeutics Inc (VYNE)'s detailed insider trading history can be found in Insider Trading Tracker table.
VYNE Therapeutics Inc Insider Transactions
Patrick G Lepore Mailing Address
Above is the net worth, insider trading, and ownership report for Patrick G Lepore. You might contact Patrick G Lepore via mailing address: 17-17 Route 208 N, Fairlawn Nj 07410.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
